Structural Basis for Potent Inhibition of Human DHODH by Quinoline-4-carboxylic Acid Derivatives
Abstract
Quinoline-4-carboxylic acid derivatives are privileged scaffolds in drug discovery, with potential as inhibitors of human dihydroorotate dehydrogenase (HsDHODH), a clinically validated target in cancer and autoimmune diseases. Here, we report computational and structural studies of a series of 6-fluoro-2-(aryl)-quinoline-4-carboxylic acids, focusing on their mechanistic basis of inhibition. Molecular docking and molecular dynamics simulations predicted stable binding of compounds 2d and 2e within the HsDHODH binding site. These findings, corroborated by MM-PBSA free energy calculations, suggest a solvent-assisted anchoring mechanism that differs from the binding mode of brequinar. Enzymatic assays confirmed nanomolar potency for compound 2d (IC50 = 27 ± 1 nM), comparable to brequinar, while other derivatives displayed micromolar activity. Crucially, X-ray crystallography of the 2d-HsDHODH complex provided direct structural confirmation of the computationally predicted binding mode. In parallel, ADME modeling predicted a lower Log P for 2d compared with brequinar, pointing to more favorable physicochemical properties. Together, these results establish compound 2d as a potent and drug-like HsDHODH inhibitor and illustrate how integrated computational and structural approaches can elucidate binding determinants of known scaffolds and guide future inhibitor design.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.